Clinical Trial Update: Cisplatin Plus Gemcitabine in Treating Patients With Advanced Squamous Cell Head and Neck Cancer [Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 2 study evaluating cisplatin plus gemcitabine in patients with advanced squamous cell head and neck…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Cisplatin (Platinol) (cisplatin)
• Gemcitabine (Gemzar) (gemcitabine)

Snippet

Sponsor: Fox Chase Cancer Center | Conditions: Head and Neck Cancer | Phase 2 | Status: COMPLETED